SCHEMBL19983036

SCHEMBL19983036

CN(C)c1ccc(/N=N/c2ccc(C(=O)NCCc3cc(F)c(O)c(F)c3)cc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.48
KDM4E B2RXH2 2/20 0.48
RAB9A P51151 2/20 0.48
MAPT P10636 1/20 0.48
MAPK1 P28482 1/20 0.48
MEN1 O00255 1/20 0.48
POLB P06746 1/20 0.48
KMT2A Q03164 1/20 0.48
ESRRG P62508 3/20 0.47
ESRRB O95718 1/20 0.47
HDAC1 Q13547 8/20 0.47
HDAC10 Q969S8 8/20 0.47
HDAC6 Q9UBN7 8/20 0.47
HDAC8 Q9BY41 7/20 0.47
HDAC2 Q92769 6/20 0.47
HDAC3 O15379 4/20 0.47
HDAC4 P56524 4/20 0.47
HDAC7 Q8WUI4 4/20 0.47
HDAC11 Q96DB2 4/20 0.47
HDAC9 Q9UKV0 4/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19983300 0.88 KDM4E (0.56) NPC1KDM4ERAB9AMAPTMAPK1
SCHEMBL24218436 0.81 KMT2A (0.56) NPC1KDM4ERAB9AMAPTMAPK1
SCHEMBL28555102 0.81 KMT2A (0.56) NPC1KDM4ERAB9AMAPTMAPK1
SCHEMBL18874959 0.79 NPC1 (0.58) NPC1KDM4ERAB9AMAPTMAPK1
SCHEMBL22793229 0.79 HDAC1 (0.59) NPC1KDM4ERAB9AMAPTMAPK1
SCHEMBL19939430 0.77 HDAC1 (0.62) NPC1KDM4ERAB9AMAPTMAPK1
SCHEMBL10103983 0.77 NPC1 (0.55) NPC1KDM4ERAB9AMAPTMAPK1
SCHEMBL13104839 0.76 HDAC1 (0.63) NPC1KDM4ERAB9AMAPTMAPK1
SCHEMBL19601260 0.76 MAPT (0.48) NPC1KDM4ERAB9AMAPTMAPK1
SCHEMBL8161491 0.75 HDAC1 (0.65) NPC1KDM4ERAB9AMAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230142714-A1 KETONE INHIBITORS OF LYSINE GINGIPAIN Cortexyme, Inc. (US) 2023-05-11 US disclosed
US-20230142714-A1 KETONE INHIBITORS OF LYSINE GINGIPAIN Cortexyme, Inc. (US) 2023-05-11 US disclosed
US-11325884-B2 Ketone inhibitors of lysine gingipain Cortexyme, Inc. (US) 2022-05-10 US disclosed
US-20210053908-A1 KETONE INHIBITORS OF LYSINE GINGIPAIN Cortexyme, Inc. (US) 2021-02-25 US disclosed
US-10730826-B2 Ketone inhibitors of lysine gingipain Cortexyme, Inc. (US) 2020-08-04 US disclosed
US-20190210960-A1 KETONE INHIBITORS OF LYSINE GINGIPAIN Cortexyme, Inc. (US) 2019-07-11 US disclosed
WO-2018053353-A1 KETONE INHIBITORS OF LYSINE GINGIPAIN Cortexyme, Inc. (US) 2018-03-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210053908-A1 KETONE INHIBITORS OF LYSINE GINGIPAIN PHYKPL, ENPEP, PREP NPC1 1179/4885KDM4E 215/4885RAB9A 4148/4885
US-20230142714-A1 KETONE INHIBITORS OF LYSINE GINGIPAIN PHYKPL, ENPEP, PREP NPC1 1179/4885KDM4E 215/4885RAB9A 4148/4885
US-10730826-B2 Ketone inhibitors of lysine gingipain PHYKPL, ENPEP, PREP NPC1 1179/4885KDM4E 215/4885RAB9A 4148/4885
US-20190210960-A1 KETONE INHIBITORS OF LYSINE GINGIPAIN PHYKPL, ENPEP, PREP NPC1 1179/4885KDM4E 215/4885RAB9A 4148/4885
US-11325884-B2 Ketone inhibitors of lysine gingipain PHYKPL, ENPEP, PREP NPC1 1179/4885KDM4E 215/4885RAB9A 4148/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.